Analysts Offer Insights on Healthcare Companies: Paragon 28 (FNA), ADMA Biologics (ADMA) and Veracyte (VCYT)
Buy Rating Affirmed for Paragon 28 Amid Revenue Growth and Positive EBITDA Outlook
Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Paragon 28 (FNA)
Paragon 28 Analyst Ratings
Buy Rating Affirmed for Paragon 28 Amid Strong Financial Performance and Strategic Growth
CCORF Maintains Paragon 28(FNA.US) With Buy Rating, Maintains Target Price $17
Paragon 28 Analyst Ratings
Paragon 28 (FNA) Gets a Buy From Piper Sandler
Paragon 28 Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Zentalis Pharmaceuticals (ZNTL) and Paragon 28 (FNA)
Paragon 28's Sustained Growth and Strategic Initiatives Bolster Buy Rating
Analysts Are Bullish on These Healthcare Stocks: Paragon 28 (FNA), Prothena (PRTA)
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Paragon 28 (FNA) and Intra-Cellular Therapies (ITCI)
Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)
Maintaining a Buy: Paragon 28's Strong Q1 Performance and Optimistic Financial Outlook Despite CFO Transition
Paragon 28 Analyst Ratings
Analysts' Top Healthcare Picks: Paragon 28 (FNA), Genmab (GMAB)
Buy Rating Affirmed for Paragon 28 on Strategic Product Launches and Strong Market Position
Paragon 28 Analyst Ratings
Needham Reiterates Buy on Paragon 28, Maintains $17 Price Target